Prev：IL‐6 increases podocyte motility via MLC‐mediated focal adhesion impairment and cytoskeleton disassembly(ABL1011-4)
Next：ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation(A23230-9)
